Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 1878  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Article Submission Resources Sections Etcetera Contact
  NAVIGATE here  
  ::   Search
  ::   Ahead of print
  ::   Current Issue
  ::   Submit Article 
  ::   Apply as Referee 
  ::   JPGM WriteCon 
  ::   Current Symposium 


This article has been cited by
1Seizure: An Adverse Effect of Regadenoson in Myocardial Perfusion Imaging
Sohab S. Radwan,Owen G. Schwartz
Case Reports in Cardiology.2019;2019()1
2Pharmacological Activity and Clinical Use of PDRN
Francesco Squadrito,Alessandra Bitto,Natasha Irrera,Gabriele Pizzino,Giovanni Pallio,Letteria Minutoli,Domenica Altavilla
Frontiers in Pharmacology.2017;8()1
3Comparative study of the safety of regadenoson between patients with mild/moderate chronic obstructive pulmonary disease and asthma
Carlos Salgado Garcia,Amelia Jimenez Heffernan,Elena Sanchez de Mora,Carlos Ramos Font,Juana Lopez Martin,Francisco Rivera de los Santos,Ignacio Ynfante Milá
European Journal of Nuclear Medicine and Molecular Imaging.2014;41(1)119
4Myocardial perfusion imaging laboratory efficiency with the use of regadenoson compared to adenosine and dipyridamole
Michelle Friedman,James Spalding,Smita Kothari,You Wu,Elyse Gatt,Luke Boulanger
Journal of Medical Economics.2013;16(4)449
5When to re-dose regadenoson?
Gregory S. Thomas,Aaron F. Jolly,Michael Safani
Journal of Nuclear Cardiology.2017;24(1)66
6A Phase 1 study evaluating AMG 337 in Asian patients with advanced solid tumors†
Hirofumi Yasui,Ning Go,Hui Yang,Benny M. Amore,A. Scott Jung,Toshihiko Doi
Japanese Journal of Clinical Oncology.2017;47(8)772
Online since 12th February '04
© 2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow